• 39
  • 4
  • Favorite

Sony delays release of ‘Venom’ sequel amid delta surge

Market Watch2021-08-13

3-week delay suggests studio believes current surge will be brief.

NEW YORK — In the biggest sign yet that Hollywood’s fall plans are being altered by the coronavirus surge driven by the delta variant, Sony Pictures on Thursday delayed the release of the big-budget sequel “Venom: Let There Be Carnage.”

Instead of opening in theaters Sept. 24, the “Venom” sequel will now debut Oct. 15. The film, starring Tom Hardy, had already been delayed numerous times during earlier stages of the pandemic.

But after constant turmoil, the fall movie calendar has stayed relatively calm until recently. Last week, Viacom CBS Paramount Pictures postponed the release of “Clifford the Big Red Dog,” citing the delta variant.

What “Venom” and “Clifford” have in common is that they’re planned as theater-only releases. Sony doesn’t have a major streaming platform the way Walt Disney and AT&T Inc's Warner Bros. do. Those studios have been relaying partly on subscription boosts or digital rentals to offset lost box office. The original “Venom” earned $856 million globally in 2018.

After ramping-up ticket sales, the box office has turned south in recent weeks. After Disney’s “Jungle Cruise” underperformed in late July, Warner Bros.’ “The Suicide Squad” opened with an underwhelming $26.2 million last weekend. Analysts have said the delta variant is keeping many moviegoers home.

But the “Venom” delay — relatively short compared to the postponements of last year — also suggests the film industry is banking on the current surge fading quickly. This weekend, Disney will release the 20th Century Fox production “Free Guy,” with Ryan Reynolds, only in theaters.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment4

  • ANGELINE
    ·2021-08-13
    [Miser] 
    Reply
    Report
    Fold Replies
    View more 2 comments
  • ETF88
    ·2021-08-13
    We are Venom
    Reply
    Report
  • ngchris
    ·2021-08-13
    Free Guy is the winner. Must watch.
    Reply
    Report
  • MugenQiang
    ·2021-08-13
    Wow...like pls..
    Reply
    Report
    Fold Replies
    • HawTK
      Good
      2021-08-13
      Reply
      Report
    • CaseySawReplying toHawTK
      ??
      2021-08-13
      Reply
      Report
    • Ku9787
      ok
      2021-08-13
      Reply
      Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24